|
시장보고서
상품코드
1964702
조제 약국용 주사제 시장 규모, 점유율, 성장 분석 : 분자별, 포장 유형별, 약국 유형별, 지역별 - 업계 예측(2026-2033년)Injectable for Compounding Pharmacy Market Size, Share, and Growth Analysis, By Molecule, By Packaging Type, By Pharmacy Type, By Region - Industry Forecast 2026-2033 |
||||||
세계의 조제 약국용 주사제 시장 규모는 2024년에 132억 달러로 평가되었으며, 2025년 142억 3,000만 달러에서 2033년까지 259억 5,000만 달러로 성장할 전망입니다. 예측 기간(2026-2033년) 동안 CAGR은 7.8%로 예측됩니다.
조제 약국용 주사제 시장은 주로 표준 제품으로는 얻을 수 없는 정밀한 용량과 전문적인 치료를 제공하는 맞춤형 무균 제제에 대한 수요 증가에 의해 주도되고 있습니다. 이 분야는 종양학, 통증관리, 소아과 등 다양한 용도의 무균 주사제를 제조하는 약국을 포함하며, 의약품 부족 시 치료의 연속성 유지와 적응증 외 사용을 지원하는 데 중요한 역할을 하고 있습니다. 소규모 병원 내 시스템에서 인증된 아웃소싱 시설로의 진화는 엄격한 규제와 오염 관리의 필요성에 의해 촉진되어 첨단 인프라와 품질 관리 시스템에 대한 투자 기회를 창출하고 있습니다. 암과 만성질환의 유병률이 증가함에 따라 제조업체와 공급업체 간의 제휴를 통해 바이오시밀러와 맞춤형 치료제의 생산이 강화되고 있으며, AI 기술은 조제 과정의 품질 관리와 업무 효율성을 향상시키고 있습니다.
조제 약국용 주사제 세계 시장 촉진요인
조제 약국의 주사제 세계 시장은 환자 개개인의 요구에 맞춘 맞춤형 의약품에 대한 수요 증가로 인해 크게 견인되고 있습니다. 이러한 개별화에 대한 강조는 이들 약국의 임상적 의미를 높이고, 서비스 제공 범위의 확대로 이어지고 있습니다. 정확한 용량과 고유한 제형 사양에 대한 요구는 무균 조제 및 전문 포장 솔루션에 대한 수요를 촉진하고 인프라 및 기술자 교육에 대한 투자를 증가시키고 있습니다. 또한, 환자별 치료법에 대한 집중은 의료 서비스 제공자와의 보다 강력한 협력을 통해 조제 솔루션을 치료 계획에 폭넓게 통합하여 맞춤형 주사제 제공에 있어 약국의 중요한 역할을 공고히 하고 있습니다.
세계 조제 약국용 주사제 시장의 억제요인
세계 조제 약국용 주사제 시장은 엄격한 규제 요건과 복잡한 규정 준수 의무로 인해 주사제 생산의 확장성을 저해하는 중대한 도전에 직면해 있습니다. 이러한 의무는 다양한 허가 기준, 무균 운영 절차, 엄격한 검사 프로세스를 준수해야 하며, 운영 비용을 증가시키고 성장 이니셔티브를 방해합니다. 품질 보증과 종합적인 문서화에 대한 지속적인 집중은 관리 리소스를 더욱 압박하고 소규모 제공자가 서비스 범위를 확장하는 것을 방해할 수 있습니다. 이러한 제약은 시설 업그레이드를 지연시키고, 신규 진입을 막고, 궁극적으로 투자 의욕을 떨어뜨려 주사제 조제 솔루션의 시장 보급을 제한하는 요인으로 작용할 수 있습니다.
세계 조제 약국용 주사제 시장 동향
전 세계 조제 약국용 주사제 시장에서는 개인별 맞춤화 및 즉시 투여 가능한 주사 요법에 대한 두드러진 추세를 볼 수 있습니다. 수요와 공급의 증가, 임상적 요구 등의 요인으로 인해 병원과 외래 진료소를 포함한 의료 서비스 제공자들은 환자별 맞춤 치료 계획에 대응하고 정밀한 용량을 유연하게 조절할 수 있는 조제 주사제 도입을 가속화하고 있습니다. 이러한 변화로 인해 조제 약국은 무균 조제 능력 강화, 엄격한 품질 보증 프로토콜 도입, 신속한 납기 대응 및 의료 전문가와의 협력 진료에 중점을 둔 서비스 모델 구축이 요구되고 있습니다. 그 결과, 이러한 진화는 환자의 안전과 업무 효율성을 높일 뿐만 아니라, 다양한 헬스케어 환경에서 약물 오투약의 위험을 최소화하는 데에도 기여하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 조제 약국용 주사제 시장 규모 : 분자별 & CAGR(2026-2033년)
세계의 조제 약국용 주사제 시장 규모 : 패키징 유형별 & CAGR(2026-2033년)
세계의 조제 약국용 주사제 시장 규모 : 약국 종류별 & CAGR(2026-2033년)
세계의 조제 약국용 주사제 시장 규모 & CAGR(2026-2033년)
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.03.23Global Injectable For Compounding Pharmacy Market size was valued at USD 13.2 Billion in 2024 and is poised to grow from USD 14.23 Billion in 2025 to USD 25.95 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
The injectable compounding pharmacy market is primarily driven by the increasing need for customized sterile preparations that offer precise dosing and specialized therapies unavailable in standard products. This sector encompasses pharmacies that prepare sterile injectables for various applications, such as oncology, pain management, and pediatric care, playing a crucial role in maintaining treatment continuity during shortages and supporting off-label use. The evolution from small hospital setups to accredited outsourcing facilities has been influenced by stringent regulations and the need for contamination control, creating opportunities for investments in advanced infrastructure and quality management systems. As the prevalence of cancer and chronic diseases rises, partnerships between manufacturers and providers enhance the production of biosimilars and tailored treatments, while AI technologies enhance quality control and operational efficiency in compounding processes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Injectable For Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Injectable For Compounding Pharmacy Market Segments Analysis
Global injectable for compounding pharmacy market is segmented by molecule, packaging type, pharmacy type and region. Based on molecule, the market is segmented into Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BKK (Bupivacaine, Ketorolac, Ketamine), RCK (Ropivacaine, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin and Others. Based on packaging type, the market is segmented into Vials, Ampoules, Prefilled Syringes and Others. Based on pharmacy type, the market is segmented into 503A Pharmacies and 503B Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Injectable For Compounding Pharmacy Market
The global market for injectable formulations in compounding pharmacies is significantly driven by the growing demand for customized medications tailored to individual patient requirements. This emphasis on personalization enhances the clinical relevance of these pharmacies, leading to an expanded service offering. The need for precise dosing and unique formulation specifications fuels the demand for sterile compounding and specialized packaging solutions, prompting increased investments in both infrastructure and technician training. Additionally, the focus on patient-specific therapies fosters stronger collaborations with healthcare providers, thereby promoting the broader integration of compounding solutions into treatment plans and solidifying the essential role of pharmacies in delivering bespoke injectable medications.
Restraints in the Global Injectable For Compounding Pharmacy Market
The global injectable compounding pharmacy market faces significant challenges due to stringent regulatory requirements and intricate compliance obligations that hinder the scalability of injectable production. These mandates necessitate adherence to various licensing standards, sterile handling practices, and rigorous inspection processes, which escalate operational costs and impede growth initiatives. The persistent focus on quality assurance and comprehensive documentation further strains administrative resources, potentially discouraging smaller providers from expanding their service offerings. Such limitations can slow facility upgrades and deter new market entrants, ultimately creating obstacles that dampen investment and restrict the widespread adoption of injectable compounding solutions in the market.
Market Trends of the Global Injectable For Compounding Pharmacy Market
The Global Injectable for Compounding Pharmacy market is witnessing a significant trend towards personalized and ready-to-administer injectable therapies. Factors such as rising supply demands and clinical needs are propelling healthcare providers, including hospitals and outpatient clinics, to increasingly adopt compounded injectables that cater to individualized patient regimens and enable precise dosing flexibility. This shift is compelling compounding pharmacies to enhance their aseptic preparation capabilities, adopt stringent quality assurance protocols, and establish service models that prioritize rapid turnaround times and collaborative care approaches with healthcare professionals. As a result, this evolution not only bolsters patient safety and operational efficiency but also minimizes the risk of medication errors across various healthcare environments.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
Global Injectable for Compounding Pharmacy Market Size by Molecule & CAGR (2026-2033)
- Market Overview
- Acetaminophen
- Phenylephrine
- Midazolam
- Esmolol
- Vancomycin
- Epinephrine
- Adenocaine
- Fentanyl/Bupivacaine
- Morphine
- Amiodarone
- Fentanyl
- Heparin
- Ketamine
- Dextrose
- Hydromorphone
- Bupivacaine
- Lidocaine
- BKK (Bupivacaine Ketorolac Ketamine)
- RCK (Ropivacaine Clonidine Ketorolac)
- RKK (Ropivacaine Ketorolac Ketamine)
- Norepinephrine
- Diltiazem
- Vasopressin
- Others
Global Injectable for Compounding Pharmacy Market Size by Packaging Type & CAGR (2026-2033)
- Market Overview
- Vials
- Ampoules
- Prefilled Syringes
- Others
Global Injectable for Compounding Pharmacy Market Size by Pharmacy Type & CAGR (2026-2033)
- Market Overview
- 503A Pharmacies
- 503B Pharmacies
Global Injectable for Compounding Pharmacy Market Size & CAGR (2026-2033)
- North America (Molecule, Packaging Type, Pharmacy Type)
- US
- Canada
- Europe (Molecule, Packaging Type, Pharmacy Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Molecule, Packaging Type, Pharmacy Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Molecule, Packaging Type, Pharmacy Type)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Molecule, Packaging Type, Pharmacy Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Fagron
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AmerisourceBergen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PCCA (Professional Compounding Centers of America)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rx3 Compounding Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compounding Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medisca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Custom Meds Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Apothecary Shoppe
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Central Admixture Pharmacy Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fillerina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nephron Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pintail Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- White Passport Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- First Choice Compounding Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compound Care Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Capstone Health Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wise Compounding Pharmacy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TheraCom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- InfuSystem Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
